Increased Prevalence of Psychopathology and Maladaptive Personality Traits after Long-Term Cure of Cushing’s Disease
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
CONTEXT AND OBJECTIVE: Psychopathology and maladaptive personality traits are often observed during the active phase of Cushing's disease (CD). We hypothesized that patients with long-term cure of CD show persistent psychopathology and maladaptive personality traits. DESIGN: Four questionnaires on frequently occurring psychopathology in somatic illnesses were used, including the Apathy Scale, Irritability Scale, Hospital Anxiety and Depression Scale, and Mood and Anxiety Symptoms Questionnaire short-form. Personality was assessed using the Dimensional Assessment of Personality Pathology short-form (DAPPs). PATIENTS AND CONTROL SUBJECTS: We included 51 patients cured of CD (16% men, 53 ± 13 yr) and 51 matched controls. In addition, we included 55 patients treated for nonfunctioning pituitary macroadenomas (55% men, 62 ± 10 yr), and 55 matched controls. RESULTS: Mean duration of remission was 11 yr (range 1-32 yr). Compared with matched controls, patients cured from CD scored significantly worse on virtually all questionnaires. Compared with nonfunctioning pituitary macroadenoma patients, patients treated for CD scored worse on apathy (P < 0.001), irritability (P < 0.001), anxiety (P < 0.001), negative affect and lack of positive affect (P < 0.001 on both scales), somatic arousal (P < 0.001), and 11 of 18 subscales of the Dimensional Assessment of Personality Pathology short-form (P < 0.05). CONCLUSIONS: Patients with long-term cured CD show an increased prevalence of psychopathology and maladaptive personality traits. These observations suggest irreversible effects of previous glucocorticoid excess on the central nervous system rather than an effect of pituitary tumors and/or their treatment in general. This may also be of relevance for patients treated with high doses of exogenous glucocorticoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term effects of postnatal GC on the human brain include decreased memory and hippocampal volume (145), decreased cerebellar cortical volume (146), diminished cognitive function (147-149), increased psychopathology, and reduced QOL (148, 150)”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [150]
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications
Clark, L. A., & Watson, D. (1991) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.100.3.316 · Cited by 4,601 · cited 1×
“There are no formal cutoff scores (15).”
SPINHOVEN, P., ORMEL, J., SLOEKERS, P. P. A., KEMPEN, G. I. J. M., SPECKENS, A. E. M., & HEMERT, A. M. V. (1997) · Psychological Medicine · doi:10.1017/s0033291796004382 · Cited by 2,158 · cited 1×
“A score greater than 8 points on one of the subscales is being used to characterize subjects as being anxious or depressed respectively (13, 14).”
MethodSyndromic Validity of Apathy in Alzheimer’s Disease
Starkstein, S. E., Petracca, G., Chemerinski, E., & Kremer, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.872 · Cited by 392 · cited 2×
“A total score of 14 points or more is being used to characterize subjects as apathetic (11, 12).”
BackgroundStarkman, M. N., Schteingart, D. E., & Schork, A. M. (1981) · Psychosomatic Medicine · doi:10.1097/00006842-198102000-00002 · Cited by 289 · cited 1×
“Psychopathology is reported to be present in the majority of patients with active Cushing’s disease (17).”
BackgroundSonino, N., & Fava, G. A. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00003 · Cited by 267 · cited 5×
“019] remained significantly different between patients and controls, whereas the traits identity problems [F (1) 3.”
BackgroundMethodInfluentialDorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260 · cited 2×
“of these patients (2, 3, 24), and the prevalence of overall psychopathology decreases to 24% of the patients within 1 yr after appropriate treatment of active Cushing’s disease (21, 22).”
BackgroundResultQuality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 253 · cited 1×
“However, these patients do not completely return to their premorbid level of functioning, and persistently impaired quality of life has been reported despite long-term cure (4).”
BackgroundEffects of Glucocorticoids on Mood, Memory, and the Hippocampus: Treatment and Preventive Therapy
Brown, E. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04981.x · Cited by 214 · cited 1×
“or exogenous exposure to glucocorticoids may have longlasting adverse effects on behavioral and cognitive functions due to functional and, over time, structural alterations in specific brain target areas (8, 9).”
BackgroundPereira, A. M., van Aken, M. O., van Dulken, H., Schutte, P. J., Biermasz, N. R., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030751 · Cited by 173 · cited 5×
“80 Medium: 13 Medium: 16 High: 18 High: 17 Surgery, n (%) 51 (100%) NA NA Postoperative radiotherapy, n (%) 11 (22%) NA NA Duration of remission (yr) 11 (9) NA NA Duration of follow-up (yr) 14 (10) NA NA Hypopituitarism, n (%) Any axis: 31 (61%) NA NA GH: 20 (39%) LH/FSH: 14 (28%) TSH: 21 (41%) ADH: 10 (20%) Hydrocort…”
BackgroundInfluential
Cited by
Items 101–142 of 142
Sabahi, M., Yousefi, O., Kehoe, L., Sasannia, S., Gerndt, C. H., Adada, B., Borghei-Razavi, H., Shahlaie, K., & Palmisciano, P. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.04.154 · Cited by 5
Fernandes, M. A., Hickle, S. D., Penna, S., Ioachimescu, A. G., & Tone, E. B. (2024) · Behavioural Neurology · doi:10.1155/2024/4393169 · Cited by 8
“Of the few studies that included an NFA control group, fi ndings indicated poorer cognitive functioning and increased prevalence of psychopathology among individuals with CD [11, 12]; however, these studies did not assess cognitive and psychiatric functioning in conjunction.”
InfluentialRajaraman, V., Ummar, I. S., & Loganathan, N. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.158194 · Cited by 5
“These observations suggest irreversible effects of previous glucocorticoid excess on the central nervous system rather than an effect of pituitary tumors and/or their treatment in general.[4] Cortisol is secreted by adrenal cortex in response to stimulation from ACTH and CRH from pituitary gland and hypothalamus respe…”
BackgroundFeldkamp, L. L. I., Müller, L., Deutschbein, T., Detomas, M., Hahner, S., Strasburger, C. J., Kunzel, H. E., Oßwald, A., Braun, L., Rubinstein, G., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad043 · Cited by 5
Quality of life in patients with pituitary tumors
Webb, S. M., Martínez-Momblán, M.-A., Resmini, E., Valassi, E., & Vives, A. S. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.02.004 · Cited by 4
Pereira, A. M., Romijn, J. A., Hermus, N.-M. A. R., ZELISSEN, P. M. J., & Webb, S. M. (2013) · Cited by 3
Recent Developments in Drug Therapy for Cushing’s Disease
van der Pas, R., de Herder, W. W., Hofland, L. J., & Feelders, R. A. (2013) · Drugs · doi:10.1007/s40265-013-0067-6 · Cited by 4
“Psychiatric and cognitive disorders, osteoporosis, and muscle and skin atrophy are also frequently observed complications in patients with CS [6, 7].”
BackgroundAnderson, R. M., Glanz, R. M., Johnson, S. B., Miller, M. M., Romig‐Martin, S. A., & Radley, J. J. (2016) · The Journal of Comparative Neurology · doi:10.1002/cne.24019 · Cited by 4
Inoue, S., Hayashi, T., Teishima, J., & Matsubara, A. (2020) · Urologia Internationalis · doi:10.1159/000508765 · Cited by 1
Neurocognitive changes after radiation to the pituitary region
Murphy, P., Mitchell, A. C., Edge, D., Shekhda, K. M., Baldeweg, S. E., & Kosmin, M. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag002 · Cited by 1
Glucocorticoid Regulation of Neurocognitive and Neuropsychiatric Function
Pereira, A. M., & Meijer, O. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_2 · Cited by 1
Coping Strategies in Patients after Treatment for Functioning or Non-Functioning Pituitary Adenomas
Tiemensma, J., Kaptein, A. A., Pereira, A. M., Smit, J. W. A., Romijn, J. A., & Biermasz, N. R. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part2.p37.p2-384 · Cited by 1
The distress and needs of Chinese patients with pituitary adenoma: a preliminary survey
Shen, M., Sheng, G., Yang, Y. X., Wu, C., Ma, C., Li, Y., & Huang, Y. (2021) · Archives of Medical Science · doi:10.5114/aoms/143886 · Cited by 1
“Our findings are similar to previous related epidemiological survey results [17, 18], in which the prevalence of prolactinoma is the highest, followed by non-functioning type, acromegaly and Cushing’s disease.”
Chouhdari, A., Rezaei, O., Samadian, M. M., Sharifi, G., Ebrahimzadeh, K., & Davoudi, Z. (2023) · Journal of Holistic Nursing and Midwifery · doi:10.32598/jhnm.33.2.2341 · Cited by 1
Bienestar psicológico de personas con síndrome de Cushing
Novoa-Gómez, M. M., Gutiérrez, R. M. V., Triana, L., & Held, Y. (2013) · Diversitas · doi:10.15332/s1794-9998.2013.0001.11 · Cited by 1
Psychiatric Disease in Hypothalamic–Pituitary Disorders
Sievers, C., & Stalla, G. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00014-3 · Cited by 1
Acromégalie et maladie de Cushing : séquelles après contrôle et l’hypersécrétion
Rochette, C., Castinetti, F., & Brue, T. C. (2016) · Annales d Endocrinologie · doi:10.1016/s0003-4266(17)30074-4 · Cited by 1
Interface de doenças endocrinológicas com repercussões psiquiátricas: uma revisão de literatura
Lafayette, D. D. S. A., Urquiza, P. A. C., Brito, E. M. C., Costa, S. P. G. A., & Cantilino, A. (2021) · Debates em Psiquiatria · doi:10.25118/2763-9037.2021.v11.271 · Cited by 1
“No entanto, mesmo após remissão da doença a dificuldade cognitiva persistiu, assim como a depressão e a ansiedade, resultando em redução da qualidade de vida [34, 41, 42].”
BackgroundGeng, W., Cui, L., Li, T., Liu, X., Yao, Y., Hong, X., Zhu, H., Lü, L., & Wei, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1190899 · Cited by 2
“Some studies suggest that anxiety symptoms tend to improve over time, although subclinical or trait anxiety may remain (6, 7, 15).”
BackgroundGlucocorticoids - outcome in patients with glucocorticoid deficiency and Cushing's syndrome
Ragnarsson, Ó. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Neuroendocrinology and Neurotransmitters
Gray, J. D., & McEwen, B. S. (2014) · Wiley eBooks · doi:10.1002/9781118775349.ch16 · Cited by 1
Long-Term Complications of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64305-2 · Cited by 2
Signs and Symptoms of Pituitary Disease
Fernández-Rodríguez, E., Bernabéu, I., Casanueva, F. F., Kassi, E. N., Kaltsas, G., Chrousos, G. P., & Golden, V. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch2
General Psychological and Psychosocial Effects of Pituitary Disorders
Golden, V. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch28
Aus der Universitätsklinik für Neurochirurgie Tübingen
Direktor, Ä., & Tatagiba, M. S. (2012)
Long-Term Effects of Prior Cushing’s Syndrome
Aulinas, A., Valassi, E., Resmini, E., Vives, A. S., Crespo, I., Barahona, M. J., & Webb, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_11
Crespo, I., & Webb, S. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00083-3
Writers, A. M. (2017) · Drugs & Therapy Perspectives · doi:10.1007/s40267-017-0444-4 · Cited by 2
Effects of Glucocorticoids on the Brain
Pereira, A. M., Webb, S. M., & Meijer, O. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64329-5
Bourdeau, I., & Forget, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-56782-2_548-3
Bengtsson, D. (2021) · Linköping University medical dissertations · doi:10.3384/diss.diva-174806 · Cited by 1
Hypercortisolism and Behavioral Neuroscience
Vives, A. S., Webb, S. M., & Resmini, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00093-1
Bourdeau, I., & Forget, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-57111-9_548
Acromegaly and Effects on Behavior and Psychology
Hatipoğlu, E., & Burhan, Ş. (2024) · Springer eBooks · doi:10.1007/978-3-031-32046-0_37-1
Long-term complications of hypercortisolism
Pivonello, R., Crescenzo, E. M., Simeoli, C., Paola, N. D., Larocca, A., & Colao, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00123-0
Psycho-Neurological and Immunological Aspects of Cushing’s Syndrome
Matos, T., Sapinho, I., Sagarribay, A., & Marques, P. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_28
Acromegaly and Effects on Behavior and Psychology
Hatipoğlu, E., & Burhan, Ş. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_37
Psychological recovery after treatment of Cushing syndrome
Pereira, A. M., & Stenvers, D. J. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag034
Effects of glucocorticoids on the brain
Pereira, A. M., Webb, S. M., & Meijer, O. C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00364-2
CS and long-term effects on health, cognition, and function
Webb, S. M., Vives, A. S., Aulinas, A., & Valassi, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00014-4
Zeng, W., Schwartz, G. M., Prasad, A., Jedwood, C., John, D., Chung, R. S., Hong, A. T., Coté, D. J., Dallas, J., Briggs, R. G., et al. (2026) · Neurosurgery · doi:10.1227/neu.0000000000004022
Practical Review of Role and Usage of Corticosteroids in Modern Neuro-Oncology Care
Lu‐Emerson, C., Lee, C., Still, M. E., Ghiaseddin, A. P., Lobbous, M., Ranjan, S., Sharma, A., Gálvez-Jiménez, N., Moor, R., Kurz, S. C., et al. (2026) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200679
Metadata
- Authors
- Tiemensma, J., Biermasz, N. R., Middelkoop, H. A. M., van der Mast, R. C., Romijn, J. A., & Pereira, A. M.
- Affiliations
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-10
- Volume
- 95
- Issue
- 10
- Pages
- E129-E141
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2140913018
- Cited by
- 142
- References
- 29
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 2 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 13 · 2017: 6 · 2016: 13 · 2015: 14 · 2014: 14 · 2013: 13 · 2012: 15
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's disease, psychopathology, maladaptive personality traits, long-term remission, apathy, irritability, anxiety, negative affect, somatic arousal, glucocorticoid excess, non-functioning pituitary macroadenoma, exogenous glucocorticoids, personality pathology
- MeSH terms
- Adaptation, Psychological, Adenoma, Adult, Aged, Mental Disorders, Female, Humans, Male, Middle Aged, Personality Disorders, Pituitary Neoplasms, Psychiatric Status Rating Scales, Psychopathology, Surveys and Questionnaires, Time Factors, Prevalence, Case-Control Studies, Pituitary ACTH Hypersecretion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.